NEXMed (NEXMD). Has seen it’s shares rise faster and harder than their Vitaros erectile dysfunction drug. Increasing girth in share price by more than 50% in Tuesday’s trading. Enough of the sexual innuendos. Bottom line is this stock will be a prime short the moment it begins to break support. For now NEXMD is holding Tuesdays intra […]